Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

1.080 -0.020 (-1.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,162
Open 1.100
Bid (Size) 1.050 (4)
Ask (Size) 1.110 (8)
Prev. Close 1.100
Today's Range 1.020 - 1.110
52wk Range 0.7007 - 5.820
Shares Outstanding 8,768,650
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024
Via ACCESSWIRE
Earnings Outlook For Biotricity
Via Benzinga

Performance

YTD
-58.83%
-58.83%
1 Month
+21.48%
+21.48%
3 Month
-48.82%
-48.82%
6 Month
-74.44%
-74.44%
1 Year
-76.32%
-76.32%

More News

Read More
Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Biotricity Releases Another Groundbreaking Product: Biotres Pro
Via ACCESSWIRE
CORRECTION BY SOURCE: Biotricity Announces Patent Filing for Cutting-Edge Biotres Device
Via ACCESSWIRE
Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations
Via ACCESSWIRE
Biotricity Achieves $14 Million Revenue Run Rate in August 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Biotricity Continues to Expand Patent Portfolio with Latest Patent Filing for Bioheart Device
Via ACCESSWIRE
Biotricity Announces Patient Filing for Cutting-Edge Biotres Device
Via ACCESSWIRE
Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
Via ACCESSWIRE
Biotricity Reports Strong Start to Fiscal Year 2024
Via ACCESSWIRE
Biotricity Predicted To Achieve 44% Annual Growth Despite Market Risks, Analyst Says
Via Benzinga
Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
Via ACCESSWIRE
Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
Via ACCESSWIRE
Biotricity's Return On Capital Employed Overview
Via Benzinga
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
Via ACCESSWIRE
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications
Via ACCESSWIRE
Biotricity Regains Nasdaq Listing Compliance
Via ACCESSWIRE
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.